Men Who Have Sex With Men and Transgender Women

Clinical trial pipeline · Data from ClinicalTrials.gov

See which Men Who Have Sex With Men and Transgender Women trials you may qualify for

Total trials

Actively recruiting

Phase 3 trials

Completed

Trial phase breakdown

Trial status

Actively recruiting — 1 trial

RecruitingPhase 4

NCT07218211

Enhancing PrEP Uptake and Retention Among Latine TGW and GBM in the South Using Long-Acting Injectable PrEP

The purpose of this project is to test a culturally-tailored, community-delivered long-acting injectable PrEP (lenacapavir) program for Latine gay and bisexual…

United States100 participantsStarted 2026-01-13

Treatment: Lenacapavir long-acting

All recent trials (37 shown)

TerminatedPhase 3

NCT04652700

Oral Islatravir (MK-8591) Once-Monthly as Preexposure Prophylaxis (PrEP) in Men and Transgender Women Who Are at High Ri…

The main purpose of the study is to evaluate the safety and tolerability of oral Islatravir (ISL) once monthly (QM) as Preexposure Prophylaxis (PrEP) in cisgend…

United States494 participantsStarted 2021-03-15

Treatment: ISL, FTC/TDF

Active — Not RecruitingPhase 3

NCT02842086

Study to Evaluate the Safety and Efficacy of Emtricitabine and Tenofovir Alafenamide (F/TAF) Fixed-Dose Combination Once…

The primary objective of this study is to assess the rates of HIV-1 infection in Men (MSM) and transgender women (TGW) who have sex with men and who are adminis…

United States5,399 participantsStarted 2016-09-02

Treatment: F/TAF, F/TDF

Men Who Have Sex With Men and Transgender Women

Trial phase breakdown

Trial status

Actively recruiting — 1 trial

Enhancing PrEP Uptake and Retention Among Latine TGW and GBM in the South Using Long-Acting Injectable PrEP

All recent trials (37 shown)

Oral Islatravir (MK-8591) Once-Monthly as Preexposure Prophylaxis (PrEP) in Men and Transgender Women Who Are at High Ri…

Study to Evaluate the Safety and Efficacy of Emtricitabine and Tenofovir Alafenamide (F/TAF) Fixed-Dose Combination Once…

Trial phase breakdown

Trial status

Actively recruiting — 1 trial

Enhancing PrEP Uptake and Retention Among Latine TGW and GBM in the South Using Long-Acting Injectable PrEP

All recent trials (37 shown)

Oral Islatravir (MK-8591) Once-Monthly as Preexposure Prophylaxis (PrEP) in Men and Transgender Women Who Are at High Ri…

Study to Evaluate the Safety and Efficacy of Emtricitabine and Tenofovir Alafenamide (F/TAF) Fixed-Dose Combination Once…

Anal HSIL Screening Algorithm

Injectable Cabotegravir Compared to TDF/FTC For PrEP in HIV-Uninfected Men and Transgender Women Who Have Sex With Men

Study of Lenacapavir for HIV Pre-Exposure Prophylaxis in People Who Are at Risk for HIV Infection

SmokefreeSGM, A Text-based Smoking Cessation Feasibility Trial for Sexual and Gender Minority Groups

SmokefreeSGM Español Pilot, Beta Testing a Text-based Smoking Cessation Intervention for Sexual and Gender Minority(SGM)…

Acceptability of the HPV Vaccine and Anal HPV in Transgender Women and Men Who Have Sex With Men: A Pilot Study

Implementing Evidence Informed Practices in Schools to Address LGBTQ Adolescent Suicide

HIV Self-Testing AND Uptake and Retention of PrEP Among Older Adolescent MSM and TGW

Thai MSM/TG Test and Treat Study

Study to Evaluate the Feasibility of Integrating the Point-of-care Testing for Sexually Transmitted Infections and HIV I…

Increasing Engagement and Improving HIV Outcomes Via HealthMPowerment

ANRS 12415 - Quali PrEP Cambodia

SNS to Increase HIV Testing Uptake and Linkage to Double Cascade Services Among Adolescent MSM and TGW in Thailand

PrEPTECH Phase 2 Study of a PrEP Telehealth Intervention

AllyQuest Adherence App Intervention for HIV-positive Men Who Have Sex With Men and Transgender Women: Pilot Trial

Equality in Caregiving: Facilitating Caregiver Mastery Among LGBT Caregivers of PLWD

Feasibility and Impact of Online HIV/STI Screening Addressed to PrEP Users in Spain

Study to Evaluate the Feasibility of Community-based Test and Treat Strategies Among Men Who Have Sex With Men and Trans…